(±)-Carnitine-d9 (chloride)
Product Sizes
1 mg
£ POA
HY-B1453S1-1MG
5 mg
£ POA
HY-B1453S1-5MG
10 mg
£ POA
HY-B1453S1-10MG
About this Product
- SKU:
- HY-B1453S1
- Additional Names:
- DL-Carnitine-d9 (chloride); DL-Levocarnitine-d9 (chloride)
- CAS Number:
- 1219386-75-0
- Extra Details:
- (±)-Carnitine-d9 (chloride) is the deuterium labeled (±)-Carnitine chloride. (±)-Carnitine chloride exists in two isomers; known as D and L. L-carnitine plays an essential role in the β-oxidation of fatty acids and also shows antioxidant; and anti-inflammatory activities.
- Molecular Weight:
- 206.72
- Purity:
- 99.69
- References:
- [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. |[2]Oyanagi E, et al. Protective action of L-carnitine on cardiac mitochondrial function and structure against fatty acidstress. Biochem Biophys Res Commun. 2011 Aug 19;412(1):61-7.|[3]Li J, et al. l-carnitine protects human hepatocytes from oxidative stress-induced toxicity through Akt-mediated activation of Nrf2 signaling pathway. Can J Physiol Pharmacol. 2016 May;94(5):517-25.|[4]Jang J, et al. l-Carnitine supplement reduces skeletal muscle atrophy induced by prolonged hindlimb suspension in rats. Appl Physiol Nutr Metab. 2016 Dec;41(12):1240-1247.|[5]Zambrano S, et al. L-carnitine attenuates the development of kidney fibrosis in hypertensive rats by upregulating PPAR-γ. Am J Hypertens. 2014 Mar;27(3):460-70.
- Research Area:
- Metabolic Disease
- Shipping Conditions:
- Ambient
- Storage Conditions:
- 4[o]C (Powder; sealed storage; away from moisture)
- Type:
- Proteins, Peptides, Small Molecules & Other Biomolecules: Small Molecules
- Pathway:
- Immunology/Inflammation;Metabolic Enzyme/Protease;NF-κB
